Date lodged: 21 June 2017
To ask the Scottish Government how it will ensure that all diabetes patients who would benefit from continuous glucose monitoring are able to access this technology.
Answered by: Aileen Campbell 29 June 2017
There is now a well-established evidence base for the benefits of Continuous Glucose Monitoring (CGM) as an aid to improve glycaemic control for a small number of people with Type 1 diabetes.
We have worked with the Scottish Diabetes Group (SDG) to develop an National Approach to support the uptake and increased provision of Continuous Glucose Monitoring (CGM).
The National Approach along with the Scottish Government funding detailed in director's letter DL(2017)13 will ensure more people than ever before will have access to this life changing technology.